(Total Views: 71)
Posted On: 01/25/2022 10:01:04 AM
Post# of 27174

$SRRA News Article - Sierra Oncology Announces Momelotinib Achieved Statistically Significant Benefit on Symptoms, Anemia and Splenic Size in the Pivotal MOMENTUM Study for Myelofibrosis https://marketwirenews.com/news-releases/sier...90824.html


My Twitter: WhyteStocks